Health Care & Life Sciences » Pharmaceuticals | Corium International Inc.

Corium International Inc.

Corium International Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.57
Market Cap
$342.93 M
Shares Outstanding
36.25 M
Public Float
26.14 M

Profile

Address
235 Constitution Drive
Menlo Park California 94025
United States
Employees -
Website http://www.coriumgroup.com
Updated 09/14/2018
Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. The firm offers its products under the brands Corplex and MicroCor.

Financials

View All
Created with Highcharts 5.0.14Corium International Inc.Net Income. Fiscal year is October-September. All values USD Thousands.13 87713 8779 9129 91228 45028 45036 70336 70347 79347 79320132014201520162017010k20k30k40k50k60k
Created with Highcharts 5.0.14Corium International Inc.Sales/Revenue. Fiscal year is October-September. All values USD Thousands.50 27050 27042 44042 44040 92140 92133 02333 02331 86431 86420132014201520162017010k20k30k40k50k60k

David L. Greenwood
Executive Chairman
Peter D. Staple
President, Chief Executive Officer & Director